Fortress Biotech Inc FBIO:NASDAQ

Last Price$0.85NASDAQ Previous Close - Last Trade as of 4:00PM ET 7/06/22

Today's Change+0.01(1.44%)
Bid (Size)$0.83 (39)
Ask (Size)$0.89 (21)
Day Low / High$0.82 - 0.89
Volume1.00
 

View Pharmaceuticals: Major IndustryPeer Comparison as of 07/06/2022

 

Fortress Biotech Inc ( NASDAQ )

Price: $0.85
Change: +0.01 (1.44%)
Volume: 1.00
4:00PM ET 7/06/2022
 
 

Ardelyx Inc ( NASDAQ )

Price: $0.62
Change: +0.01 (1.98%)
Volume: 659.00
4:00PM ET 7/06/2022
 
 

Clearside Biomedical Inc ( NASDAQ )

Price: $1.41
Change: -0.06 (4.08%)
Volume: 111.1 K
4:00PM ET 7/06/2022
 
 

Capricor Therapeutics Inc ( NASDAQ )

Price: $3.61
Change: -0.12 (3.22%)
Volume: 93.4 K
4:00PM ET 7/06/2022
 
 

HOOKIPA Pharma Inc ( NASDAQ )

Price: $1.78
Change: +0.10 (5.95%)
Volume: 394.1 K
4:00PM ET 7/06/2022
 

Read more news Recent News

Sector Update: Health Care Stocks Stumble Through Tuesday Trading
4:12PM ET 5/31/2022 MT Newswires

Health care stocks continued to lose ground Tuesday afternoon, with the NYSE Health Care Index sinking 1.2% and the SPDR Health Care Select Sector ETF...

Sector Update: Health Care Stocks Lagging Broader Tuesday Markets, Most Other Sectors
1:44PM ET 5/31/2022 MT Newswires

Health care stocks still were mostly lower this afternoon, with the NYSE Health Care Index sinking 0.9% and the SPDR Health Care Select Sector ETF (XLV)...

Fortress Biotech Unit Doses First Patient in Early-Stage Gout Trial in US
11:06AM ET 5/31/2022 MT Newswires

Fortress Biotech (FBIO) said Tuesday its UR-1 Therapeutics unit has dosed the first patient in a phase 1 trial of Dotinurad for the treatment of gout in...

-- Earnings Flash (FBIO) FORTRESS BIOTECH Reports Q1 Revenue $23.9M, vs. Street Est of $20.7M
4:04PM ET 5/12/2022 MT Newswires

...

Company Profile

Business DescriptionFortress Biotech, Inc. engages in the manufacture and commercialization of novel pharmaceutical products and product candidates. It operates through the Dermatology Product Sales and Pharmaceutical and Biotechnology Product Development segments. Its products include Ximino, Targadox, Exelderm, Ceracade, and Luxamend. The company was founded in 2006 and is headquartered in Bay Harbor Islands, FL. View company web site for more details
Address1111 Kane Concourse
Bay Harbor Islands, Florida 33154
Phone+1.781.652.4500
Number of Employees88
Recent SEC Filing06/27/20228-K
Chairman, President & Chief Executive OfficerLindsay Allan Rosenwald
Chief Financial Officer, Secretary & TreasurerRobyn M. Hunter
Senior Vice President-Biologics OperationsGeorge C. Avgerinos
Director & Vice Chairman-Strategic DevelopmentMichael Sean Weiss

Company Highlights

Price Open$0.84
Previous Close$0.85
52 Week Range$0.77 - 3.81
Market Capitalization$90.8 M
Shares Outstanding107.4 M
SectorHealth Technology
IndustryPharmaceuticals: Major
Next Earnings Announcement08/15/2022

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$1.05
Beta vs. S&P 500N/A
Revenue$26.9 M
Net Profit Margin-88.31%
Return on Equity-70.33%

Analyst Ratings as of 02/25/2021

Buy
6
Overweight
0
Hold
0
Underweight
0
Sell
0
Consensus RecommendationConsensus Icon
Powered by Factset